B16F10 In Vitro RNA Expression Analysis Assay (Northern Blooting)

This assay is to provide B16F10-based In Vitro RNA Expression Analysis Assay (Northern Blooting) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

B16F10

Mouse

B16F10 cell line (from Mus musculus C57BL/6J strain) is a convenient and widely used experimental model of highly metastatic melanoma to study cytotoxicity, migration, metastatic spread and tissue invasion. B16-F10 is a cell line exhibiting a morphology of spindle-shaped and epithelial-like cells that was isolated from skin tissue of a mouse with melanoma. Use these cells in your skin cancer research.

B16-F10

Melanoma

Oncology

In Vitro RNA Expression Analysis Assay (Northern Blooting)

B16F10-cell based In Vitro RNA Expression Analysis Assay (Northern Blooting)

Northern blotting is a conventional method used to analyze RNA levels. In northern blotting, mRNA isolated from cells or tissues are quantified by gel electrophoresis and transferred to membranes and incubated with suitable probes. The probes are normally labeled with chemiluminescent substrates or radioactive isotopes. Bound RNA-probe complexes are visualized on X-ray films.

Gene and Protein Expression Assays

Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.